Literature DB >> 10403408

Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain.

J Zhong1, K Iqbal, I Grundke-Iqbal.   

Abstract

Unlike normal tau, abnormally hyperphosphorylated tau (AD P-tau) from Alzheimer disease (AD) does not promote but instead inhibits microtubule assembly and disrupts already formed microtubules. Tau in the human neuroblastoma cell line SH-SY5Y is hyperphosphorylated at several of the same sites as AD P-tau, and accumulates in the cell body without any association to the cellular microtubule network. The aim of the present study was to elucidate why the SY5Y tau does not affect the viability of the cells. We found that, like AD P-tau, SY5Y tau because of hyperphosphorylation does not bind to microtubules and inhibits the tau-promoted assembly of microtubules. However, the tau/HMW MAP ratio is about 10 times less in SY5Y cells than in AD brain. These findings suggest that the hyperphosphorylated tau from SY5Y cells has similar biological characteristics as AD P-tau from AD brain, but is not lethal to the SY5Y cells because of its low tau/HMW MAP ratio.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403408     DOI: 10.1016/s0014-5793(99)00715-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

Authors:  Jonathan Wills; Jessica Jones; Thomas Haggerty; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  Exp Neurol       Date:  2010-06-28       Impact factor: 5.330

2.  Transgenic mouse and cell culture models demonstrate a lack of mechanistic connection between endoplasmic reticulum stress and tau dysfunction.

Authors:  M L Spatara; A S Robinson
Journal:  J Neurosci Res       Date:  2010-07       Impact factor: 4.164

3.  Alzheimer's disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR-edited human neuronal cells.

Authors:  Yang You; Samuel W Hersh; Roshanak Aslebagh; Scott A Shaffer; Seiko Ikezu; Jesse Mez; Kathryn L Lunetta; Mark W Logue; Lindsay A Farrer; Tsuneya Ikezu
Journal:  Aging Cell       Date:  2022-05-14       Impact factor: 11.005

4.  Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.

Authors:  Zhi Tang; Erika Bereczki; Haiyan Zhang; Shan Wang; Chunxia Li; Xinying Ji; Rui M Branca; Janne Lehtiö; Zhizhong Guan; Peter Filipcik; Shaohua Xu; Bengt Winblad; Jin-Jing Pei
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

5.  Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.

Authors:  Jonathan Wills; Joel Credle; Thomas Haggerty; Jae-Hoon Lee; Adam W Oaks; Anita Sidhu
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

6.  Quercetin Increases Mitochondrial Biogenesis and Reduces Free Radicals in Neuronal SH-SY5Y Cells.

Authors:  Chia-Ling Ho; Ning-Jo Kao; Ching-I Lin; Tzu-Wen L Cross; Shyh-Hsiang Lin
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.